3005840
print

Quantitative Detection of BCR-ABL1, Major Form (p210)

QNT BCRMAJ
Example Reports
Detected
Enhanced Report
Not Detected

Icon

Time Sensitive

Icon

Additional Technical Information

Ordering Recommendation

This quantitative test is appropriate for therapeutic monitoring of BCR-ABL1 major (p210) positive chronic myeloid leukemia (CML) or acute lymphoblastic leukemia/lymphoma (ALL). This test is designed to meet the current National Comprehensive Cancer Network (NCCN) guidelines and is recommended for detection of minimal residual disease (MRD). 

For patients with uncertain diagnoses or unknown forms of BCR-ABL1 fusion transcripts, consider ordering Diagnostic Qualitative BCR-ABL1 Assay with Reflex to p190 or p210 Quantitative Assays (3005839).

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation
Collect

Whole blood or bone marrow in lavender (EDTA).

Specimen Preparation

Whole blood: Transport 5 mL whole blood. (Min: 3 mL)
Bone marrow: Transport 3 mL bone marrow. (Min: 1 mL)
Refrigerate immediately. Specimens must be received within 48 hours of collection due to lability of RNA.

Storage/Transport Temperature

Whole blood and bone marrow: CRITICAL REFRIGERATED. Separate specimens must be submitted when multiple tests are ordered.

Unacceptable Conditions

Serum, plasma, extracted DNA, CSF, FFPE tissue, ambient whole blood, or frozen whole blood or bone marrow.
Specimens collected in anticoagulants other than EDTA. Severely hemolyzed or clotted specimens.
Ambient bone marrow specimens past 7 days will be canceled.
Refrigerated whole blood or bone marrow specimens past 7 days will be canceled.

Remarks

This quantitative test is recommended for therapeutic monitoring and detection of minimal residual disease for patients with an established diagnosis. For patients with uncertain diagnoses or unknown forms of BCR-ABL1 fusion transcripts, please order Diagnostic Qualitative BCR-ABL1 Assay with Reflex to p190 or p210 Quantitative Assays (ARUP test code 3005839).

Stability

Ambient: Unacceptable; Refrigerated: 48 hours; Frozen: Unacceptable

Methodology

Reverse Transcription Polymerase Chain Reaction

Performed

Varies

Reported

5-9 days

Reference Interval

Interpretive Data

Refer to report.

Compliance Category

Laboratory Developed Test (LDT)

Note

This test does not detect the BCR-ABL1 micro (p230) or minor (p190) fusion transcripts. This test does not detect rare BCR-ABL1 major (p210) forms involving beyond ABL1 exon 2.

For the p190 fusion form (minor breakpoint), order BCR-ABL1, Minor (p190), Quantitative (ARUP test code 2005016).

Hotline History

View Hotline History

 

Hotline History

Date of Change
Test Name Change
Methodology
Performance/Reported Schedule
Specimen Requirements
Reference Interval
Interpretive Data
Note
CPT Code
Component Change
Other Interface Change
New Test
Inactive
11/14/2022
X
N/A

CPT Codes

81206

Are you an ARUP Client? Click here for your pricing.

Components

Component Test Code* Component Chart Name LOINC
3005854 Quant BCR-ABL1, Major (p210), Source 31208-2
3005855 Quant BCR-ABL1, Major (p210), Result 42714-6
3005856 Quant BCR-ABL1, Major (p210), IS Percent 69380-4
3005858 Quant BCR-ABL1, Major (p210), EER 11526-1
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • BCR::ABL1
  • p210
  • Philadelphia chromosome Ph major, bone marrow/blood
  • Quantitative RT-PCR, CML or ALL
  • t(9;22) major by quantitative RT-PCR
Quantitative Detection of BCR-ABL1, Major Form (p210)